TO THE QUESTION OF THE RISK OF POSTMATECTOMY LYMPHEDEMA IN PATIENTS WITH BREAST CANCER AND ITS CONNECTION WITH CONCOMITANT VASCULAR PATHOLOGY

Djurayev Mirjalol Dekhanovich; Uzokov Sokhib Makhsudovich; Kutlumuratov Atabek  Bekchanovich; Esankulova Bustonoy Sobirovna

doi:10.5281/zenodo.10057478

TO THE QUESTION OF THE RISK OF POSTMATECTOMY LYMPHEDEMA IN PATIENTS WITH BREAST CANCER AND ITS CONNECTION WITH CONCOMITANT VASCULAR PATHOLOGY

31.10.2023 International Scientific Journal "Science and Innovation". Series D. Volume 2 Issue 10

Djurayev Mirjalol Dekhanovich, Uzokov Sokhib Makhsudovich, Kutlumuratov Atabek Bekchanovich, Esankulova Bustonoy Sobirovna

Abstract. Investigation resultsof influence of radical mastectomy (RME) combined with lymphatic-venous anastomosis (RME+LVA) to the 5-year survival of patients with breast cancer (BC), to current of BC, and to the risk of development secondary postmastectomy lymphedema (VL), and to its link with symptoms of atherosclerosis, ischemic illness of heart, coronary sclerosis, stenocardia, vascular diseases of the brain, neurocirculatory dystonia and hypertensive disease (HD) are presented. It is shown that RME+LVA effectively reduces risk of SL at patients with BC, not influencing current breast cancer, their 5-year-old survival, and that, probably, risk of VL is linked to the factors which prevent development of HD

Keywords: radical mastectomy, anastomosis, breast cancer, lymphedema

References:

1. Allegra C. Morphological and functional changes of the microlymphatic network in patients with advancing stages of primary lymphedema / C. Allegra, R. Sarcinella, MJ Bartolo // Lymphology. - 2002. - Vol. 35. No. 3.- P. 114-120. 2. Asdourian MS, Skolny MN, Brunelle C. ea Precautions for breast cancer-related lymphoedema: Risk from air travel, ipsilateral arm blood pressure measurements, skin puncture, extreme temperatures, and cellulitis. Lancet Oncol 2016; 17:e392-405. 3. Aspelund A., Robciuc MR, Karaman S. ea Lymphatic System in Cardiovascular Medicine. Circ. Res. 2016, 118, 515–530. 4. Cormier JN, Askew RL, Mungovan KS ea Lymphedema beyond breast cancer: A systematic review and meta-analysis of cancer-related secondary lymphedema. Cancer 2010, 116, 5138–5149. 5. DiSipio T., Rye S., Newman B. ea Incidence of unilateral arm lymphoedema after breast cancer: A systematic review and meta-analysis. Lancet Oncol 2013;14:500-15. 6. Ferguson CM, Swaroop MN, Horick N.eaImpact of ipsilateral blood draws, injections, blood pressure measurements, and air travel on the risk of lymphedema for patients treated for breast cancer. J Clin Oncol 2016;34:691-8. 7. Gillespie TC, Sayegh HE, Brunelle CL ea Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments. Gland Surg 2018;7(4):379-403. 8. Grada AA, Phillips TJ (December 2017). "Lymphedema: Diagnostic workup and management".Journal of the American Academy of Dermatology. 77(6):995-1006. 9. Kim M., Kim SW, Lee SU ea A model to estimate the risk of breast cancer-related lymphedema: Combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy // Int.J.Radiat Oncol Biol Phys 2013;86:498-503. 10. Lim HY, Thiam CH, Yeo KP ea Lymphatic vessels are essential for the removal of cholesterol from peripheral tissues by SR-BI-mediated transport of HDL. // Cell Metab., 2013, 17, 671–684. 11. Lymfo-Veneuse Anastomosen Ter Preventie Van Lymphoedem. University Hospital, Ghent.: https://ichgcp.net/ru/clinical-trials-registry/NCT05601037 12. Martel C., Li W., Fulp B. ea Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice. J. Clin. Investing. 2013, 123, 1571–1579. 13. Mortimer PS, Rockson SG New developments in clinical aspects of lymphatic disease. J. Clin. Investig. 2014, 124, 915–921. 14. Parkin D., Hakulinen T. Analysis of survival. In: Jensen OM, Parkin DM, MacLennan R, Muir CS and Skeet RG (eds) Cancer Registration, Principles and Methods. IARC Sci. Publ. No. 95. IARC Press, Lyon, 1991; pp. 159–176. 15. Randolph GJ; Miller NE Lymphatic transport of high-density lipoproteins and chylomicrons. J. Clin. Investig. 2014, 124, 929–935. 16. Sayegh HE, Asdourian MS, Swaroop MNeaDiagnostic methods, risk factors, prevention, and management of breast cancer-related lymphedema: Past, present, and future directions. Curr Breast Cancer Rep 2017;9:111-21. 17. Shah C., Vicini FA Breast cancer-related arm lymphedema: Incidence rates, diagnostic techniques, optimal management and risk reduction strategies. Int J Radiat Oncol Biol Phys 2011; 81:907-14. 18. Siegel R., Naishadham D., Jemal A. Cancer Statistics, 2013 // CA Cancer J. Clin. - 2013; 63:11-30. 19. Small DM, Bond MG, Waugh D. ea Physicochemical and histological changes in the arterial wall of nonhuman primates during progression and regression of atherosclerosis. J. Clin. Investig. 1984, 73, 1590–1605. 20. Swaminathan R., Brenner H. Statistical methods for cancer survival analysis // IARC Scientific Publications volume 162, ISBN 978-92-832-2162-3, Lyon, International Agency for Research on Cancer, 2011. 21. Telinius N., Hjortdal V.E. Role of the lymphatic vasculature in cardiovascular medicine. Heart 2019, 105, 1777–1784. 22. Tsai RJ, Dennis LK, Lynch CF ea The risk of developing arm lymphedema among breast cancer survivors: A meta-analysis of treatment factors. Ann Surg Oncol 2009;16:1959-72. 23. Vuorio T., Nurmi H., Moulton K. ea Lymphatic vessel insufficiency in hypercholesterolemic mice alters lipoprotein levels and promotes atherogenesis. Arter. Thromb. Vasc. Biol. 2014, 34, 1162–1170. 24. Wang X., Rader DJ Molecular regulation of macrophage reverse cholesterol transport. Curr. Opin. Cardiol. 2007, 22, 368–372. 25. Zalutsky I.V., Antonenkova N.N., Zhukovets A.G. Complex treatment of patients with postmastectomy lymphedema of the extremities using lymphatic drainage operations / I.V. // Annals of plastic, reconstructive and aesthetic surgery. - 2002. - No. 4. - P. 50-51. 26. Ivanov O.A. Method for processing a database of cancer patients (survival): Method. Recommendations. – M. – 1997. – p. 97. 27. Kolomiets E. A., Kurmukov I. A., Sandomirskaya A. P., Kashiya Sh. R. Comorbidity in oncology: results of preoperative examination of patients in a specialized oncology clinic / Abstracts of the XXI Russian Oncology Congress. // Malignant tumors. – 2017, V.7, No. 3, 1s. – P.171-172. 28. Lakin G.F. Biometrics. – M.: Higher. school. – 1990. – 352 p. 29. Magomedov O.M., Magomedova P.O., Magomedov G.M. Cardivascular complications in the treatment of breast cancer // Russian Journal of Cardiology 2010. - No. 1 (81). -– pp. 73-76. 30. Mamedov M.N., Badeinikova K.K., Karimov A.K. Targets for the prevention of comorbidity of cardiovascular diseases and cancer // Russian Journal of Cardiology 2022;27(11): 5235. P.115-120; doi:10.15829/1560-4071-2022-5235;https://russjcardiol.elpub.ru. 31. Collection of standards and clinical protocols for the diagnosis and treatment of malignant cancer / Team of compilers, ed. prof., doctor of medical sciences M.N. Tillyashaikhova. - Tashkent. - 2017. – 254 p. 32. Strelkov R.B. Statistical tables for express calculations of the standard error and confidence limits at zero or one hundred percent value of experimental and clinical data indicators/MZSSSR, AMNSSSR, Scientific Research Institute of Med. Radiol. - Obninsk, 1982. – 45 p. 33. Uzakov S.M., Juraev M.D., Karimova M.N. Modern ideas about post-matectomy lymphedema, methods of its treatment and prevention (literature review) // Journal of Biomedicine and Practice - No. 1 (2022) – P. 179-188.